Clinical Trials Directory

Trials / Completed

CompletedNCT00933634

Efficacy and Safety of Electrical Versus Pharmacological Cardioversion in Early Atrial Fibrillation

Efficacy and Safety of Electrical Versus Pharmacological Cardioversion in Early Atrial Fibrillation: a Randomized Controlled Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
247 (estimated)
Sponsor
Valduce Hospital · Academic / Other
Sex
All
Age
18 Years – 85 Years
Healthy volunteers
Not accepted

Summary

The optimal strategy to restore sinus rhythm in patients with atrial fibrillation (AF) of less than 48 hours' duration is still controversial. The investigators performed a controlled single-center trial to compare electrical and pharmacological (propafenone) cardioversion to restore the sinus rhythm in selected patients with acute atrial fibrillation.

Conditions

Interventions

TypeNameDescription
PROCEDUREelectrical cardioversionExternal cardioversion was performed in anteroposterior position (right sternal body at the third intercostal space-angle of the left scapula); patients were submitted to a biphasic wave-form sequential shock of 100-150-200 J, if necessary.
DRUGpropafenonePropafenone (2 mg/kg bolus) was administered to obtain pharmacolgic sinus rhythm conversion.

Timeline

Start date
2006-01-01
Primary completion
2008-11-01
Completion
2008-11-01
First posted
2009-07-07
Last updated
2009-07-07

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT00933634. Inclusion in this directory is not an endorsement.